| [1] |
Jia Weiping. Diabetes: a challenge for China in the 21st century[J]. Lancet Diabetes Endocrinol, 2014, 2(4): e6-7.
|
| [2] |
Waldman SA,Terzic A. Cardiovascular Health: The Global Challenge[J]. Clinical pharmacology & Therapeutics, 2011, 90(4):483-485.
|
| [3] |
Tashiro Y,Sato K,Watanabe, et al. A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis[J]. Peptides, 2014, 54:19-26.
|
| [4] |
Yin Qinghua,Zhang Rui,Li Li, et al. Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice[J]. Journal of biological chemistry, 2016, 291(51):26487-26501.
|
| [5] |
Klucken J,hrista Büchler C,Orsó E, et al. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport[J]. Proc Natl Acad Sci U S A, 2000, 97(2):817-822.
|
| [6] |
Kennedy MA,Barrera GC,Nakamura K, et al. ABCG1 has a critical role inmediating cholesterol efflux to HDL and preventing cellular lipid accumulation[J].Cell Metabolism, 2005, 1(2):121-131.
|
| [7] |
Wang Nan,Lan Debin,Chen Wengen, et al. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins[J], Proc Natl Acad Sci U S A, 2004, 101(26): 9774-9779.
|
| [8] |
Cserepes J,Szentpetery Z,Seres L, et al. Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization[J]. Biochemical and biophysical research communications Biochem Biophys Res Commun, 2004, 320(3): 860-867.
|
| [9] |
Kruit JK,Wijesekara N,Westwell-Roper C, et al. Loss of both ABCA1 and ABCG1 results in increased disturbances in islet sterol homeostasis, inflammation, and impaired β-cell function[J]. Diabetes, 2012, 61(3): 659-664.
|
| [10] |
El Bouhassani M,Gilibert S,Moreau M, et al. Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis[J]. Journal of biological chemistry, 2011, 286(19): 17227-17238.
|
| [11] |
Chroni A,Nieland TJ,Kypreos KE, et al. SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux[J]. Biochemistry, 2005, 44(39):13132-13143.
|
| [12] |
Yancey PG,de la Llera-Moya M,Swarnakar S, et al. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI[J]. Journal of biological chemistry, 2000, 275(47):36596-36604.
|
| [13] |
Zhang Wenwu,Yancey PG,Su YR, et al. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice[J]. Circulation, 2003, 108(18): 2258-2263.
|
| [14] |
Horton JD,Goldstein JL,Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver[J]. Journal of clinical investigation, 2002, 109(9): 1125-1131.
|
| [15] |
Terasaka N,Hiroshima A,Koieyama T, et al. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice[J]. FEBS Letters, 2003, 536(1-3):6-11.
|
| [16] |
Larrede S,Quinn CM,Jessup W, et al. Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent[J]. Arteriosclerosis thrombosis and vascular biology, 2009, 29(11): 1930-1936.
|
| [17] |
Laffitte BA,Repa JJ,Joseph SB, et al. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes[J]. Proc Natl Acad Sci U S A, 2001, 98(2):507-512.
|
| [18] |
Malerod L,Juvet LK,Hanssen-Bauer A, et al. Oxysterol-activated LXRa/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes[J]. Biochem Biophys Res Commun, 2002, 299(5): 916-923.
|
| [19] |
Repa JJ,Liang Guosheng,Ou Jiafu, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta[J]. Genes & Development, 2000, 14(22): 2819-2830.
|
| [20] |
Chinetti G,Gbaguidi FG,Griglio S, et al. CLA-1/SR-BI is expressed in atherosclero10.1016/j.atherosclerosis.2012.03.005tic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors[J]. Circulation, 2000, 101 (20): 2411-2417.
|
| [21] |
Chinetti G,Lestavel S,Bocher V, et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway[J]. Nature Medicine, 2001, 7 (1)53-58.
|
| [22] |
Chawla A,Boisvert WA,Lee CH, et al. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and Atherogenesis[J]. Molecular Cell, 2001, 7(1):161-171.
|
| [23] |
Malerod L,Sporstol M,Juvet LK, et al. Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor gamma and hepatocyte nuclear factor 4alpha[J]. Biochem Biophys Res Commun, 2003, 305(1):557-565.
|
| [24] |
Oliver WR JR,Shenk JL,Snaith, MR, et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport [J]. Proc Natl Acad Sci USA, 2001, 98(9), 5306-11.
|
| [25] |
Nadkarni P,Chepurny OG,Holz GG. Regulation of glucose homeostasis by GLP-1[J]. Progress in molecular biology and translational science, 2014, 121:23-65.
|
| [26] |
Song Xiaoyan,Jia Hetang,Jiang Yuebo, et al. Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta analysis [J]. Scientific Reports, 2015, 26(5):10202.
|
| [27] |
Sun Feng,Wu Shanshan,Wang Jing, et al. Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis [J]. Clinical Therapeutics, 2015, 37(1):225-241.
|
| [28] |
Wang Yangui,Yang Tianlun. Liraglutide reduces oxidized LDL-induced oxidative stress and fatty degeneration in Raw 264.7 cells involving the AMPK/SREBP1 pathway [J]. Journal of Geriatric Cardiology, 2015, 12(4): 410-416.
|
| [29] |
Hu Yanwei,Yang Junyao,Ma Xin, et al. A Lin cRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-Dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis[J]. Journal of Lipid Research, 2014, 55(4):681-697.
|
| [30] |
Chehade JM,Alcalde R,Naem E, et al. Induction of apolipoprotein A-I gene expression by glucagon-like peptide-1 and exendin-4 in hepatocytes but not intestinal cells[J]. Metabolism, 2013, 62(2):265-274.
|
| [31] |
Ben-Shlomo S,Zvibel I,Rabinowich L, et al. Dipeptidyl peptidase 4-deficient rats have improved bile secretory function in high fat diet-induced steatosis[J]. Digestive diseases and sciences, 2013, 58(1):172-178.
|
| [32] |
Fryirs MA,Barter PJ,Appavoo M, et al. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion[J]. Arterioscler Thromb Vasc Biol, 2010, 30(8):1642-1648.
|
| [33] |
Cochran BJ,Bisoendial RJ,Hou L, et al. Apolipoprotein A-I increases insulin secretion and production from pancreatic beta-cells via a G-protein-cAMPPKA-FoxO1-dependent mechanism[J]. Arterioscler Thromb Vasc Biol, 2014, 34(10):2261-2267.
|
| [34] |
Li Junhua,Murao K,Imachi H, et al. Exendin-4 regulates pancreatic ABCA1 transcription via CaMKK/CaMKIV pathway[J]. Journal of Cellular and Molecular Medicine J Cell Mol Med , 2010, 14(5):1083-1087.
|
| [35] |
Brunham LR,Kruit JK,Pape TD, et al. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment[J]. Nature Medicine, 2007, 13(3):340-347.
|